Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Poly Polymerase 2 market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Poly Polymerase 2market, defines the market attractiveness level of Poly Polymerase 2 market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Poly Polymerase 2 industry, describes the types of Poly Polymerase 2 market, the applications of major players and the market size, and deeply analyzes the current situation of the global Poly Polymerase 2 market and the development prospects and opportunities of Poly Polymerase 2 industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Poly Polymerase 2 market in Chapter 13.
By Player:
BeiGene Ltd
Eisai
AstraZeneca Plc
AbbVie Inc
Clovis Oncology Inc
Tesaro Inc
Jiangsu Hengrui Medicine Co Ltd
Shanghai Acebright Pharmaceuticals Group Co Ltd
Ildong Pharmaceutical Co Ltd
By Type:
BGB-290
AZ-0108
CK-102
NOV-1401
Others
By End-User:
Peritoneal Cancer
B-Cell Chronic Lymphocytic Leukemia
Laryngeal Cancer
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Poly Polymerase 2 Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Poly Polymerase 2 Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Poly Polymerase 2 Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Poly Polymerase 2 Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Poly Polymerase 2 Market Analysis and Outlook to 2022
-
7.1 Global Poly Polymerase 2 Consumption (2017-2022)
-
7.2 United States Poly Polymerase 2 Consumption (2017-2022)
-
7.3 Europe Poly Polymerase 2 Consumption (2017-2022)
-
7.4 China Poly Polymerase 2 Consumption (2017-2022)
-
7.5 Japan Poly Polymerase 2 Consumption (2017-2022)
-
7.6 India Poly Polymerase 2 Consumption (2017-2022)
-
7.7 South Korea Poly Polymerase 2 Consumption (2017-2022)
8 Region and Country-wise Poly Polymerase 2 Market Analysis and Outlook to 2028
-
8.1 Global Poly Polymerase 2 Consumption Forecast (2022-2028)
-
8.2 United States Poly Polymerase 2 Consumption Forecast (2022-2028)
-
8.3 Europe Poly Polymerase 2 Consumption Forecast (2022-2028)
-
8.4 China Poly Polymerase 2 Consumption Forecast (2022-2028)
-
8.5 Japan Poly Polymerase 2 Consumption Forecast (2022-2028)
-
8.6 India Poly Polymerase 2 Consumption Forecast (2022-2028)
-
8.7 South Korea Poly Polymerase 2 Consumption Forecast (2022-2028)
9 Global Poly Polymerase 2 Market Outlook by Types and Applications to 2022
-
9.1 Global Poly Polymerase 2 Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global BGB-290 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global AZ-0108 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global CK-102 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global NOV-1401 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Poly Polymerase 2 Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Peritoneal Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global B-Cell Chronic Lymphocytic Leukemia Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Laryngeal Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Poly Polymerase 2 Market Outlook by Types and Applications to 2028
-
10.1 Global Poly Polymerase 2 Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global BGB-290 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global AZ-0108 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global CK-102 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global NOV-1401 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Poly Polymerase 2 Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Peritoneal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global B-Cell Chronic Lymphocytic Leukemia Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Laryngeal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Poly Polymerase 2 Import and Export Analysis (Top 5 Countries)
-
11.1 Global Poly Polymerase 2 Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Poly Polymerase 2 Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Poly Polymerase 2 Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Poly Polymerase 2 Market Competitive Analysis
-
14.1 BeiGene Ltd
-
14.1.1 BeiGene Ltd Company Details
-
14.1.2 BeiGene Ltd Poly Polymerase 2 Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 BeiGene Ltd Poly Polymerase 2 Product and Service
-
14.2 Eisai
-
14.2.1 Eisai Company Details
-
14.2.2 Eisai Poly Polymerase 2 Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Eisai Poly Polymerase 2 Product and Service
-
14.3 AstraZeneca Plc
-
14.3.1 AstraZeneca Plc Company Details
-
14.3.2 AstraZeneca Plc Poly Polymerase 2 Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 AstraZeneca Plc Poly Polymerase 2 Product and Service
-
14.4 AbbVie Inc
-
14.4.1 AbbVie Inc Company Details
-
14.4.2 AbbVie Inc Poly Polymerase 2 Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 AbbVie Inc Poly Polymerase 2 Product and Service
-
14.5 Clovis Oncology Inc
-
14.5.1 Clovis Oncology Inc Company Details
-
14.5.2 Clovis Oncology Inc Poly Polymerase 2 Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Clovis Oncology Inc Poly Polymerase 2 Product and Service
-
14.6 Tesaro Inc
-
14.6.1 Tesaro Inc Company Details
-
14.6.2 Tesaro Inc Poly Polymerase 2 Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Tesaro Inc Poly Polymerase 2 Product and Service
-
14.7 Jiangsu Hengrui Medicine Co Ltd
-
14.7.1 Jiangsu Hengrui Medicine Co Ltd Company Details
-
14.7.2 Jiangsu Hengrui Medicine Co Ltd Poly Polymerase 2 Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Jiangsu Hengrui Medicine Co Ltd Poly Polymerase 2 Product and Service
-
14.8 Shanghai Acebright Pharmaceuticals Group Co Ltd
-
14.8.1 Shanghai Acebright Pharmaceuticals Group Co Ltd Company Details
-
14.8.2 Shanghai Acebright Pharmaceuticals Group Co Ltd Poly Polymerase 2 Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Shanghai Acebright Pharmaceuticals Group Co Ltd Poly Polymerase 2 Product and Service
-
14.9 Ildong Pharmaceutical Co Ltd
-
14.9.1 Ildong Pharmaceutical Co Ltd Company Details
-
14.9.2 Ildong Pharmaceutical Co Ltd Poly Polymerase 2 Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Ildong Pharmaceutical Co Ltd Poly Polymerase 2 Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Poly Polymerase 2
-
Figure Poly Polymerase 2 Picture
-
Table Global Poly Polymerase 2 Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Poly Polymerase 2 Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Poly Polymerase 2 Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Poly Polymerase 2 Consumption by Country (2017-2022)
-
Figure United States Poly Polymerase 2 Consumption and Growth Rate (2017-2022)
-
Table Europe Poly Polymerase 2 Consumption and Growth Rate (2017-2022)
-
Figure China Poly Polymerase 2 Consumption and Growth Rate (2017-2022)
-
Figure Japan Poly Polymerase 2 Consumption and Growth Rate (2017-2022)
-
Figure India Poly Polymerase 2 Consumption and Growth Rate (2017-2022)
-
Figure South Korea Poly Polymerase 2 Consumption and Growth Rate (2017-2022)
-
Figure Global Poly Polymerase 2 Consumption Forecast by Country (2022-2028)
-
Figure United States Poly Polymerase 2 Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Poly Polymerase 2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Poly Polymerase 2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Poly Polymerase 2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Poly Polymerase 2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Poly Polymerase 2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global BGB-290 Consumption and Growth Rate (2017-2022)
-
Figure Global AZ-0108 Consumption and Growth Rate (2017-2022)
-
Figure Global CK-102 Consumption and Growth Rate (2017-2022)
-
Figure Global NOV-1401 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Peritoneal Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global B-Cell Chronic Lymphocytic Leukemia Consumption and Growth Rate (2017-2022)
-
Figure Global Laryngeal Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global BGB-290 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AZ-0108 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CK-102 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NOV-1401 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Peritoneal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global B-Cell Chronic Lymphocytic Leukemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Laryngeal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Poly Polymerase 2 Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Poly Polymerase 2 Export by Region (Top 5 Countries) (2017-2028)
-
Table BeiGene Ltd (Foundation Year, Company Profile and etc.)
-
Table BeiGene Ltd Poly Polymerase 2 Sales, Price, Value and Gross Profit (2017-2022)
-
Table BeiGene Ltd Poly Polymerase 2 Product and Service
-
Table Eisai (Foundation Year, Company Profile and etc.)
-
Table Eisai Poly Polymerase 2 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Poly Polymerase 2 Product and Service
-
Table AstraZeneca Plc (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Plc Poly Polymerase 2 Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Plc Poly Polymerase 2 Product and Service
-
Table AbbVie Inc (Foundation Year, Company Profile and etc.)
-
Table AbbVie Inc Poly Polymerase 2 Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Inc Poly Polymerase 2 Product and Service
-
Table Clovis Oncology Inc (Foundation Year, Company Profile and etc.)
-
Table Clovis Oncology Inc Poly Polymerase 2 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Clovis Oncology Inc Poly Polymerase 2 Product and Service
-
Table Tesaro Inc (Foundation Year, Company Profile and etc.)
-
Table Tesaro Inc Poly Polymerase 2 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tesaro Inc Poly Polymerase 2 Product and Service
-
Table Jiangsu Hengrui Medicine Co Ltd (Foundation Year, Company Profile and etc.)
-
Table Jiangsu Hengrui Medicine Co Ltd Poly Polymerase 2 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jiangsu Hengrui Medicine Co Ltd Poly Polymerase 2 Product and Service
-
Table Shanghai Acebright Pharmaceuticals Group Co Ltd (Foundation Year, Company Profile and etc.)
-
Table Shanghai Acebright Pharmaceuticals Group Co Ltd Poly Polymerase 2 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shanghai Acebright Pharmaceuticals Group Co Ltd Poly Polymerase 2 Product and Service
-
Table Ildong Pharmaceutical Co Ltd (Foundation Year, Company Profile and etc.)
-
Table Ildong Pharmaceutical Co Ltd Poly Polymerase 2 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ildong Pharmaceutical Co Ltd Poly Polymerase 2 Product and Service
-
